Lanean...
Targeting RET-rearranged non-small-cell lung cancer: future prospects
Non-small-cell lung cancer (NSCLC) patients with mutated or rearranged oncogene drivers can be treated with upfront selective inhibitors achieving higher response rates and longer survival than chemotherapy. The RET gene can undergo chromosomal rearrangements in 1%–2% of all NSCLC patients, involvin...
Gorde:
| Argitaratua izan da: | Lung Cancer (Auckl) |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6433115/ https://ncbi.nlm.nih.gov/pubmed/30962732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S192830 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|